A National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Phase II Study of Oral Fludarabine in Untreated B-Cell Chronic Lymphocytic Leukemia.
暂无分享，去创建一个
L. Rassenti | T. Kipps | L. Shepherd | C. Shustik | P. Desjardins | A. Sadura | R. Turner | L. Larratt | L. Fernandez | S. Rubin | A. Duncan | D. Rizi | D. Li